Withdrawn applications Remove Withdrawn applications filter Paediatric investigation plans Remove Paediatric investigation plans filter Shortages Remove Shortages filter
Withdrawal type
Post-authorisation Remove Post-authorisation filter Initial authorisation (174) Apply Initial authorisation filter
Withdrawal date
Additional monitoring (12) Apply Additional monitoring filter Conditional approval (1) Apply Conditional approval filter Exceptional circumstances (1) Apply Exceptional circumstances filter Orphan medicine (5) Apply Orphan medicine filter
Medicine Shortages Remove Shortages filter Paediatric investigation plans Remove Paediatric investigation plans filter Withdrawn applications Remove Withdrawn applications filter
Withdrawal type Post-authorisation Remove Post-authorisation filter
Withdrawn application: Opdivo
nivolumab, date of withdrawal: 27/06/2018, Post-authorisation, Last updated: 11/12/2018
Withdrawn application: Sutent
sunitinib, date of withdrawal: 26/06/2018, Post-authorisation, Last updated: 17/08/2018
Withdrawn application: Qtern
saxagliptin / dapagliflozin, date of withdrawal: 03/04/2018, Post-authorisation, Last updated: 27/04/2018
Withdrawn application: Aranesp
darbepoetin alfa, date of withdrawal: 21/02/2018, Post-authorisation, Last updated: 24/04/2018
Withdrawn application: Zydelig
idelalisib, date of withdrawal: 30/01/2018, Post-authorisation, Last updated: 23/02/2018
Withdrawn application: Keytruda
pembrolizumab, date of withdrawal: 11/10/2017, Post-authorisation, Last updated: 28/11/2017
Withdrawn application: Xgeva
denosumab, date of withdrawal: 13/01/2017, Post-authorisation, Last updated: 05/05/2017
Withdrawn application: Translarna
ataluren, date of withdrawal: 06/03/2017, Post-authorisation, Last updated: 24/03/2017
Withdrawn application: Arzerra
ofatumumab, date of withdrawal: 08/11/2016, Post-authorisation, Last updated: 16/12/2016
Withdrawn application: Adempas
riociguat, date of withdrawal: 11/08/2016, Post-authorisation, Last updated: 16/09/2016
Withdrawn application: Rienso
ferumoxytol, date of withdrawal: 19/01/2015, Post-authorisation, Last updated: 27/02/2015
Withdrawn application: Teysuno
tegafur / gimeracil / oteracil, date of withdrawal: 06/01/2015, Post-authorisation, Last updated: 23/01/2015
Withdrawn application: Protelos
strontium ranelate, date of withdrawal: 21/03/2014, Post-authorisation, Last updated: 01/07/2014
Withdrawn application: Osseor
Withdrawn application: Tasigna
nilotinib, date of withdrawal: 21/05/2014, Post-authorisation, Last updated: 27/06/2014
Withdrawn application: Votrient
pazopanib, date of withdrawal: 27/03/2014, Post-authorisation, Last updated: 25/04/2014
Withdrawn application: Firazyr
icatibant, date of withdrawal: 14/02/2014, Post-authorisation, Last updated: 21/02/2014
Withdrawn application: Prometax
rivastigmine, date of withdrawal: 21/11/2013, Post-authorisation, Last updated: 18/02/2014
Withdrawn application: Exelon
Withdrawn application: Ceprotin
human protein C, date of withdrawal: 22/10/2014, Post-authorisation, Last updated: 21/11/2013
Withdrawn application: Effentora
fentanyl, date of withdrawal: 11/07/2013, Post-authorisation, Last updated: 29/08/2013
Withdrawn application: Eviplera
emtricitabine / rilpivirine / tenofovir disoproxil, date of withdrawal: 16/07/2013, Post-authorisation, Last updated: 26/07/2013
Withdrawn application: Tysabri
natalizumab, date of withdrawal: 14/05/2013, Post-authorisation, Last updated: 31/05/2013